Chronic-Dose Safety and Efficacy Study of Albuterol Inhaler in Pediatric Asthmatics

Study Title
A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
Teva Identifier
ABS-AS-303
ClinicalTrials.gov Identifier
NCT02126839
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Albuterol MDPI | Drug: Placebo | Drug: ProAir HFA inhaler

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
4 Years to 11 Years
Trial Duration
05/01/2014 - 02/01/2015
Phase
Phase 3

Study Type

Interventional